Rolfe Pancreatic Cancer Foundation

Rolfe Pancreatic Cancer Foundation Pancreatic cancer is the 4th leading cause of cancer related deaths in the United States.

Rolfe Pancreatic Cancer Foundation is dedicated to providing personal support to those affected by pancreatic cancer through tailored resources, connections and education, and funding for early detection research. Over 43,000 Americans are diagnosed with pancreatic cancer each year and sadly, only 4% will survive five years. Yet in 2010, the National Cancer Institute allocated only 2% of its funding to pancreatic cancer research.

Approximately 10% of patients diagnosed with pancreatic cancer in its early stages can become disease-free after treatme...
08/28/2026

Approximately 10% of patients diagnosed with pancreatic cancer in its early stages can become disease-free after treatment.

10% is not good enough.

At Rolfe, we’re committed to changing that number by supporting research, advancing early detection, and helping create better outcomes for every patient.

We believe better outcomes are possible. 💜

Help us change the future of pancreatic cancer. Donate today to support Rolfe’s mission: https://ow.ly/IUjz50ZGhiv.

Receiving a pancreatic cancer diagnosis can feel scary, but you don’t have to face it alone. 💜 Rolfe Foundation walks be...
08/27/2026

Receiving a pancreatic cancer diagnosis can feel scary, but you don’t have to face it alone. 💜

Rolfe Foundation walks beside you: understanding options, connecting with trusted doctors, and someone to talk to—at no cost.

📞 773.989.1108
💌 [email protected]
🌐 rolfefoundation.org

Today is a monumental day for the pancreatic cancer community! ✨After decades of research, clinical trials, and hope for...
08/26/2026

Today is a monumental day for the pancreatic cancer community! ✨

After decades of research, clinical trials, and hope for something new, daraxonrasib has received FDA approval for certain adults with metastatic pancreatic adenocarcinoma.

This approval is more than a headline. It is a powerful reminder of what pancreatic cancer research can make possible, and of what can happen when our community continues to push progress forward.

We’ve been waiting for news like this. And today, we get to celebrate it together. 💜

We know this news may bring questions. If you or a loved one wants to learn more about Rasonque (daraxonrasib) and what this approval means, please reach out to us. We’re here to help.

👉 Read the full FDA announcement: https://ow.ly/gfF450ZFOtl

💜 Introducing Dr. Mitchell C. Posner, one of our 2026 Rolfe Resilience Award Honorees.For more than 20 years, Dr. Posner...
08/25/2026

💜 Introducing Dr. Mitchell C. Posner, one of our 2026 Rolfe Resilience Award Honorees.

For more than 20 years, Dr. Posner has been a valued partner of Rolfe. As one of the first physicians funded by Rolfe at the University of Chicago, he has dedicated his career to advancing pancreatic cancer research, treatment, and education.

A nationally recognized leader in surgical oncology, Dr. Posner has authored more than 300 scientific publications and helped shape the future of cancer care through research, clinical trials, and mentorship.

We are honored to recognize Dr. Posner for his lasting impact on the pancreatic cancer community and his commitment to advancing care, inspiring future leaders, and moving progress forward.

✨ Learn more about Dr. Posner and the 2026 Progress Forward Gala: https://ow.ly/RBK850ZBCWv

⚾ You can’t buy a better night at Wrigley.Cubs baseball? Check.Rooftop views? Check.Good cause? Check.Tickets left? Bare...
08/24/2026

⚾ You can’t buy a better night at Wrigley.

Cubs baseball? Check.
Rooftop views? Check.
Good cause? Check.
Tickets left? Barely. 👀

Join Rolfe’s Young Professionals Board on 9/1 for a night of baseball, community, and supporting the fight against pancreatic cancer.

🎟️ Grab one of the few remaining tickets before they’re gone: https://ow.ly/YX0s50Zz4J4



📷 Wrigley Rooftops

Did you know there are two main categories of pancreatic tumors?More than 95% are exocrine tumors, while endocrine tumor...
08/21/2026

Did you know there are two main categories of pancreatic tumors?

More than 95% are exocrine tumors, while endocrine tumors make up about 5%. 🧬 But what makes these two types different, and why does that distinction matter?

🔗 Learn more about the different types of pancreatic cancer and what you should know about each: https://ow.ly/EQg950ZBCKG

08/20/2026

💬 What’s one question you wish you had asked your doctor sooner?

Rachel Sheinkop shares why it’s important to ask questions, seek second opinions, and stay informed about clinical trials and new developments in pancreatic cancer research.

There’s more to learn. More to ask about. More reason to stay informed.

🎧 Listen to the full conversation on YouTube, Spotify, or Apple Podcasts: https://ow.ly/MuB550ZBCBC

💜 Introducing Ken Brown, one of our 2026 Rolfe Resilience Award Honorees.Diagnosed with pancreatic cancer in 2013, Ken w...
08/18/2026

💜 Introducing Ken Brown, one of our 2026 Rolfe Resilience Award Honorees.

Diagnosed with pancreatic cancer in 2013, Ken was fortunate to receive an early diagnosis and successful treatment. Since then, he has turned his experience into a mission to raise awareness, support others facing pancreatic cancer, and fund research that can give more people the chance he had.

Ken doesn’t just talk about resilience. He lives it. From hiking Mt. Kilimanjaro with his cancer surgeon to competing in sprint triathlons for the first time at age 74, Ken continues to inspire others and show that anything is possible.

We are honored to celebrate Ken’s advocacy, generosity, and unwavering commitment to the pancreatic cancer community.

✨ Learn more about Ken and the 2026 Progress Forward Gala: https://ow.ly/lgK550Zz4AF

On , we’re reminded that Rolfe Pancreatic Cancer Foundation wouldn’t be where we are today without the incredible suppo...
08/17/2026

On , we’re reminded that Rolfe Pancreatic Cancer Foundation wouldn’t be where we are today without the incredible support of our donors, volunteers, partners, advocates, and the pancreatic cancer community. 💜

Together, we share one goal: a world without pancreatic cancer.

Every person who gives, volunteers, advocates, or shares our mission brings us one step closer to earlier detection, better treatments, and ultimately, a cure.

We’re grateful to have you with us in this fight.

🧬 More than 90% of pancreatic cancers have KRAS mutations, making KRAS one of the most common genetic drivers of the dis...
08/14/2026

🧬 More than 90% of pancreatic cancers have KRAS mutations, making KRAS one of the most common genetic drivers of the disease.

For years, KRAS was considered difficult to target. Now, researchers are developing new KRAS inhibitors, with promising tumor responses emerging in clinical trials.

So, what exactly is KRAS, and why does it matter for pancreatic cancer?

💬 Comment “KRAS” and we’ll send you a message with more information.

Address

4255 N Honore Street, Ste 209
Chicago, IL
60613

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Telephone

+17739891108

Website

Alerts

Be the first to know and let us send you an email when Rolfe Pancreatic Cancer Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share